Abstract
Introduction
Regular physical activity is essential for health and well-being and has been shown to contribute to the prevention of many illnesses [1] [2] [3] [4] , as well as being a vital element in the treatment, rehabilitation, and management of many conditions [5] [6] [7] . Physical activity is defined as "any bodily movement produced by skeletal muscles that results in the expenditure of energy" [8] and can be quantified either in terms of mobility (e.g., number of steps) or energy expenditure. Mobility is central to our quality of life. Mobility limitation is often the first noticeable sign of declining function and is associated with reduced independence and disability [9] , longer hospital stays [10] , nursing home placement [11] , and mortality [9] . Measuring physical activity, and particularly mobility, allows clinicians to understand a patient's functional ability and to decide upon treatment or prognosis. Physical activity and mobility have traditionally been assessed by questionnaires, surveys, and activity diaries. These assessment methods are easy to administer to large groups and can be performed at low cost [12] . However, the subjectivity of these tests means that they have limitations [13] . They may lack the precision needed to detect small changes in physical activity and mobility, and the granularity to characterise daily fluctuations in disease severity. They may also be vulnerable to error caused by manual input either by the patient or the investigator/clinician.
The proliferation of unobtrusive, wearable devices has made it easier to capture objective data relevant to physical activity and mobility. Wearable monitors, which are used to estimate physical activity and mobility, can be broadly classified into one of three types: pedometers, accelerometers, and multisensor systems. Pedometers (e.g., Yamax Digi-Walker) estimate the number of steps taken through mechanical (using a spring-mounted level arm) or digital measurements in only the vertical plane [14] . Accelerometers (e.g., RT3 accelerometer) detect acceleration in one (uniaxial), two (biaxial), or three (triaxial) directions and can determine the quantity and intensity of movement [14] . Multisensor systems (e.g., SenseWear Armband) combine accelerometry with other sensors measuring data such as heart rate, galvanic skin response, or temperature, yielding more data to base physical activity estimations upon.
Using body-worn activity monitors may provide a more robust, objective, and detailed method of assessing physical activity and mobility than traditional assessment methods such as questionnaires and standardised tests. The objective data provided may support the clinical decision-making process, assisting clinicians to better visualise changes in motor function. Furthermore, utilising wearable activity monitors permits continuous patient monitoring by allowing data collection in the patient's own home [15] . These out-of-clinic data may provide a more accurate representation of the patient's ability, as some patients perform better in the clinical environment when under the observation of a clinician [16] , while others perform better in the familiar environment of their own home. This approach also has the potential to reduce the burden on both the patient and the clinical site by decreasing the utilisation of valuable resources.
Recent years have witnessed a significant growth in the array of activity monitors with considerable clinical potential. However, despite their potential, they have not yet been widely employed in clinical practice. This may be due to the fact that there is relatively little evidence regarding the accuracy of these activity monitors, and the lack of regulatory approval for many devices. Clinicians may also have concerns related to data privacy and the security of the data produced by these devices. Other cited barriers to their clinical utilisation include the lack of understanding of how to summarise the data gathered to produce meaningful outcome measures that can inform the clinical decision-making process, and also the lack of standards for implementing these devices clinically [17] .
A number of reviews have been published which have examined the validity and reliability of using wearable sensors to measure physical activity in chronic lung disease and in stroke patients [14, 18, 19] . The studies included in these reviews were highly heterogeneous in terms of the type of activity monitor used, the activity monitor outcome reported, and the methods used for data collection and analysis. Nonetheless, the evidence presented suggests that multiaxial accelerometer or multisensor devices appear to produce the most valid and reliable data about physical activity in chronic disease populations [14, 18, 19] . A recent systematic review concluded that remote physical activity monitoring is feasible in individuals with neurological diseases, including those with moderate-to-severe disability [20] . Another recent review which evaluated a range of wearable and non-wearable devices for objectively measuring a range of motor symptoms in Parkinson disease (PD) highlighted that while a number of devices can be recommended, further clinimetric testing and clinical validation are required [21] . As yet, no review has broadly summarised the evidence regarding the validity and reliability of wearable activity monitoring in patients with neurological conditions for clinical use. The validity and reliability of activity monitoring in other populations may not translate easily to individuals with neurological diseases, as activity monitoring in individuals with neurological diseases may be complicated by a wide range of neurological impairments such as gait abnormalities [22] , weakness [23] , spasticity [24] , or tremor [25] . For example, it has been demonstrated that gait parameters such as speed and distance can be accurately estimated using a triaxial accelerometer device in healthy adults [26] , but the accuracy is not as high in individuals with PD while using the same device [27] . Therefore it is important to explore the validity and reliability of activity monitors in this population before these monitors can be widely implemented in clinical trials and practice.
The aim was to conduct a systematic review to examine the literature reporting on the validity and reliability of activity monitoring in individuals with neurological disorders. This review sought to explore the range of activity monitors that have been evaluated in clinical research studies and to explore the outcome measures of physical activity produced by these monitors. The focus of this review was on the clinical application of activity monitors and was not concerned with studies reporting early developments or validations of algorithms for activity monitoring devices.
Materials and Methods
This review was conducted and is reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [28] .
Data Sources
The PubMed and CINAHL electronic databases were searched to retrieve relevant articles. These databases were chosen based on the method used in previous literature reviews published in the field [14, 19, 29] . Pilot searches conducted in other electronic databases did not yield applicable results. A search constraint of articles published in the English language, including human participants, between January 2008 and March 2017 was applied. Due to the rapid development of technology in this field, this time frame was selected so as to limit the activity monitors studied to those which are still commercially available.
Search Strategy
The search in PubMed for relevant studies was performed using the free-text and MeSH terms outlined in Appendix 1. The search terms used in the PubMed search were modified for the CINAHL database. The citation lists from all the included studies were also searched, and a search of breadcrumb-related articles was also performed. The search strategy used was developed in consultation with a librarian.
Study Selection
The focus of this review was on an examination of the validity and/or reliability of the range of activity monitors that have been clinically utilised to quantify physical activity and mobility in patients with neurological disorders. Validity and reliability measures are referred to as psychometric properties. Validity refers to how well a test measures what it is purported to measure. Criterion validity was explored in this study, i.e., comparing the activity monitor measurement to a criterion measure of physical activity/mobility. Reliability is the degree to which an assessment tool produces stable and consistent results. The reliability or validity of an assessment tool is indicated by a coefficient, such as the intraclass coefficient or Pearson's Validation and reliability studies of physical activity monitors are highly heterogeneous. Therefore the inclusion/exclusion criteria outlined in Table 1 were applied for the selection of studies included in this review. Studies performed in laboratory, clinical, or free-living (home/community) environments were included. The abstracts and titles of the studies identified from the search process were assessed and screened by the authors in order to decide whether they were suitable for inclusion [19] . The full-text articles of all potentially relevant studies were then retrieved and assessed for inclusion by the authors based on the defined study inclusion/exclusion criteria.
Data Extraction
Data extracted from each study included the following: characteristics of the study participants, study setting, devices used (make, model, size, weight, and manufacturer), study protocol/methods, outcomes measured, and the validity/reliability of measurement produced. The methodological quality of the validation studies included in this review was assessed using an adapted version of the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) framework [18, 31] . Due to the heterogeneity of the included studies, a metaanalysis was not possible.
Results
A total of 3,693 potentially relevant articles were retrieved from the literature search performed in the PubMed and CINAHL electronic databases. Figure 1 depicts the study flow throughout the review process. Following a review of the title and abstract and a removal of duplicates, 42 articles remained. The list was subsequently reduced to 22 articles following a review of the full text. One article was retrieved from the citation search/breadcrumb search of the included articles. This yielded a final total of 23 articles for inclusion in this review. (6) walking 3 m at one's own pace; (7) walking 15 m at the preferred speed while counting backward from 100 to 0 in steps of 5; and (8) walking 15 m at the preferred speed while carrying a tray with two cups filled with water.
All tasks were videotaped. The gait characteristics as observed on video were taken as the gold standard
Gait duration
Step count
Gait duration during all tasks
Absolute percentage error DynaPort: 11.1±4.5
Step Step count
Step The participants were asked to walk along a 16-m walkway in a quiet corridor at their normal speed using walking aids as required for a period of 2 min. An observer manually recorded the participants' step counts using a manual step counter
Step count All: MD (SD) 27 (11) The participants were instructed to wear the monitor for 3 days and for the same 3 days the following week, removing it for sleeping and showering
Step Step length Difference between DynaPort and gold standard: <16%
In case of a longer walking distance, the LOA were -43 and +41%. The difference between the results and the gold standard did exceed more than 40% The study included young healthy participants as well; however, the results are presented only for the population of interest.
Table 2 (continued)
A detailed description of each study included in this review is presented in Table 2 . The methodological quality of each validation study is presented in Appendix 2. Overall the methodological quality of the studies examined was high, with each scoring ≥7. Of the assessed studies, 10 included participants with multiple sclerosis [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] , 7 included participants after stroke [32, 33, [42] [43] [44] [45] [46] , 4 included participants with PD [27, 33, 47, 48] , 3 included participants with a spinal cord injury [32, 49, 50] , 2 included participants with cerebral palsy [51, 52] , 2 included participants with a traumatic brain injury [32, 42] , and participants with Rett syndrome [53] and muscular dystrophy [32] were included in 1 study each. The most frequently used monitors included the StepWatch activity monitor (a biaxial accelerometer) [39, 41, 42, 44, 53] , the ActiGraph GT3X (a triaxial accelerometer) [35, 39, 40, 50] , the SWA (a multisensor device) [46, 49, 52] , and the Digi-Walker pedometer [27, 32, 34, 42] . Table 3 outlines the monitors that were used in the included studies, the outcome measures produced, and the findings reported regarding the validity and reliability of the measurements produced.
Discussion
This review identified 23 studies examining the validity and reliability of 16 different monitors (9 triaxial accelerometer-type monitors, 1 biaxial accelerometer-type monitor, 2 uniaxial accelerometer-type monitors, 3 multisensor devices, and 1 spring-mounted lever arm pedometer-type monitor) in individuals with neurological disorders. The studies included in this review were highly heterogeneous in terms of their study design, the participants included, the activity monitors used, the placement of the monitor on the body, the outcomes measured, and the algorithms used to calculate the measurement outcome. Therefore it was difficult to directly compare the findings. Nevertheless an attempt was made to summarise the key findings of the papers.
Step counts are the most frequently reported outcome measure of physical activity in individuals with neurological disorders, and the evidence suggests that ankle-worn biaxial or triaxial accelerometer-type devices provide the most accurate measurement. There is conflicting evidence regarding the validity and reliability of wearable activity monitors in measuring activity counts, while accelerometer-type devices appear to be more appropriate in estimating energy expenditure than multisensor devices, which are more frequently used. The sections below describe these findings in greater detail.
Ankle-Worn Devices Provide the Most Accurate Measurement of Step Counts
Step counts are the most frequently reported outcome measure of physical activity in individuals with neurological disorders. The evidence suggests that for accurate and reliable measurements of step counts, a number of factors need to be considered. Firstly the validity and reliability of wearable activity monitors in measuring step counts appears to be dependent on the type of device that is used. Spring-mounted lever arm pedometers appear to underestimate step counts in participants with a range of neurological disorders, particularly at slower walking speeds, and are also less accurate for short walking trajectories [27, 32, 42] . Similarly uniaxial accelerometers appear to underestimate steps in slower walking conditions [38, 51] . Using multiaxial accelerometers appears to be a less speed-dependent method of counting steps, producing more accurate measurements [27, 35, 39, 42, 44, 53] . The validity and reliability of wearable activity monitors in measuring step counts also appears to be dependent upon the position on the body in which the device is placed. Activity monitors positioned on the ankle appear to be more accurate than wrist-mounted and waist-mounted devices in counting steps, particularly during slow walking conditions [39, 42, 43] . This may be because larger accelerations occur at the ankle during walking due to the distance from Step count The total step count has excellent test-retest reliability when used for 3 days in individuals with stroke; monitoring for less than a 3-day period is not recommended due to high variability Rett syndrome (27) Home
Step 
Clinic
Step count Undercounts steps (percent error: 24-35%) in a neurological population; however, this is not strongly related to walking speed Stroke (46) Clinic
Step count Reliably counts steps; wearing it on the knee is a valid option for measuring steps, except during high-intensity walking; the device is more valid as walking speed increases PD (34)
Laboratory
Step count Underestimates step counts (percent error: left, 11.1%; right, 16.3%) and is less accurate for short trajectories and as the walking pace decreases ABI, acquired brain injury; CC, correlation coefficient; CP, cerebral palsy; EE, energy expenditure; ICC, intra-class correlation coefficient; LOA, limits of agreement; MS, multiple sclerosis; MVPA, moderate-to-vigorous-intensity physical activity; PD, Parkinson disease; SCI, spinal cord injury; TBI, traumatic brain injury.
the pivot point of the hip. Many device manufacturers recommend that monitoring devices are best positioned at the waist for usability reasons. However, wearing a device around the waist in the centre of the back is considered uncomfortable by many, especially when sitting and driving [33] , making long-term adherence in the home environment a challenge to achieve. Therefore, for accurate step count measurements in individuals with neurological disorders, it is recommended, based on the evidence, to use biaxial or triaxial accelerometertype devices, positioning the device around the ankle.
Validity and Reliability of Accelerometer Activity Counts
A number of studies have reported accelerometer activity counts as a measure of physical activity [33-36, 40, 45, 50] ; however, the evidence is conflicting regarding the validity and reliability of this measure in patients with neurological disorders. Some authors report good reliability in measuring activity counts during free-living activities from an activity monitor positioned at the waist [33, 36, 45] . However, others found that an accelerometer positioned around the waist was not reliable at measuring activity counts during sedentary and freeliving activities [34] . Two studies reported on the validity of activity count outputs from accelerometers, and conflicting findings were also reported [34, 50] .
Multisensor Devices Are Inaccurate in Estimating Energy Expenditure
Four studies included in this review reported on the accuracy of using a wearable device in estimating energy expenditure in this population. Multisensor devices such as the SWA are most frequently used to estimate energy expenditure, but this device was shown to be inaccurate in estimating energy expenditure in this population [27, 49, 52] . Similarly, the multisensor Intelligent Device for Energy Expenditure and Activity (IDEEA) was shown to be inaccurate in estimating energy expenditure [52] . Accelerometer devices may be more appropriate for estimating energy expenditure. The Actical triaxial accelerometer was shown to have excellent day-to-day reliability in estimating energy expenditure during free-living physical activities in individuals with stroke living in the community [45] .
Limitations
There are a number of limitations to this review that need to be considered. The majority of the studies identified in this review include a small sample of participants. In addition the majority of the studies were conducted in a controlled laboratory or clinical setting, and much more work is required to establish the accuracy of measurements in free-living environments. Despite the best efforts of the authors, it is possible that some studies were not identified in the literature search, or were excluded given the study selection criteria and the electronic databases that were searched to retrieve studies. However, given the systematic approach that was adopted, this review can be accepted as an accurate reflection of the existing evidence exploring activity monitoring in individuals with neurological disorders. Nonetheless this is a rapidly expanding and evolving field of research; therefore the findings of this review should be substantiated as new evidence emerges and new studies are published.
Recommendations for Clinical Use
Activity monitors selected for clinical use should be confined to those for which there is a body of evidence outlining the validity and the reliability of the measurements produced. In addition the psychometric properties of the monitor selected should be established in the clinical cohort of interest, as the validity and reliability of a monitor in one cohort does not
